FilingReader Intelligence
Shree Ganesh Remedies Q1 revenue flat, profit drops 26%
August 2, 2025 at 06:49 AM UTC•By FilingReader AI
Shree Ganesh Remedies Limited reported Q1FY26 revenue of ₹24.67 crore, flat year-on-year, while profit fell 26% to ₹3.44 crore. EBITDA margins dropped to 29.6%.
The company attributed the decline to contract repricing in its CRAMS business, European market headwinds, and intensifying domestic competition.
Despite challenges, new CRAMS projects are underway with a pilot facility expected to complete this quarter.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
Supplementary Source Documents
BSE:SGRL•Bombay Stock Exchange
News Alerts
Get instant email alerts when Shree Ganesh Remedies publishes news
Free account required • Unsubscribe anytime